v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
ATM
Common Stock
Common Stock
ATM
Additional Paid-in Capital
Additional Paid-in Capital
ATM
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ 118,620   $ 3   $ 390,057   $ 23 $ (271,463)
Beginning Balance, shares at Dec. 31, 2024     32,619,663          
Vesting of restricted stock units, Shares     101,280          
Stock-based compensation expense 3,432       3,432      
Unrealized loss on marketable securities (44)           (44)  
Cumulative translation adjustment arising during the period (1)           (1)  
Net loss (30,202)             (30,202)
Ending Balance at Mar. 31, 2025 91,805   $ 3   393,489   (22) (301,665)
Ending Balance, shares at Mar. 31, 2025     32,720,943          
Beginning Balance at Dec. 31, 2024 118,620   $ 3   390,057   23 (271,463)
Beginning Balance, shares at Dec. 31, 2024     32,619,663          
Net loss (53,289)              
Ending Balance at Jun. 30, 2025 71,158   $ 3   395,950   (43) (324,752)
Ending Balance, shares at Jun. 30, 2025     32,799,724          
Beginning Balance at Mar. 31, 2025 91,805   $ 3   393,489   (22) (301,665)
Beginning Balance, shares at Mar. 31, 2025     32,720,943          
Issuance of stock under the employee stock purchase plan 98       98      
Issuance of stock under the employee stock purchase plan, shares     78,781          
Stock-based compensation expense 2,363       2,363      
Unrealized loss on marketable securities (21)           (21)  
Net loss (23,087)             (23,087)
Ending Balance at Jun. 30, 2025 71,158   $ 3   395,950   (43) (324,752)
Ending Balance, shares at Jun. 30, 2025     32,799,724          
Beginning Balance at Dec. 31, 2025 147,444   $ 7   508,544   11 (361,118)
Beginning Balance, shares at Dec. 31, 2025     68,874,944          
Issuance of common stock   $ 1,507       $ 1,507    
Issuance of common stock, Shares       237,500        
Exercise of stock options 7       7      
Exercise of stock options, Shares     2,848          
Vesting of restricted stock units, Shares     52,666          
Stock-based compensation expense 2,855       2,855      
Unrealized loss on marketable securities (70)           (70)  
Net loss (17,763)             (17,763)
Ending Balance at Mar. 31, 2026 133,980   $ 7   512,913   (59) (378,881)
Ending Balance, shares at Mar. 31, 2026     69,167,958          
Beginning Balance at Dec. 31, 2025 $ 147,444   $ 7   508,544   11 (361,118)
Beginning Balance, shares at Dec. 31, 2025     68,874,944          
Exercise of stock options, Shares 2,848              
Net loss $ (35,575)              
Ending Balance at Jun. 30, 2026 119,533   $ 7   516,336   (117) (396,693)
Ending Balance, shares at Jun. 30, 2026     69,259,517          
Beginning Balance at Mar. 31, 2026 133,980   $ 7   512,913   (59) (378,881)
Beginning Balance, shares at Mar. 31, 2026     69,167,958          
Issuance of stock under the employee stock purchase plan 110       110      
Issuance of stock under the employee stock purchase plan, shares     86,114          
Vesting of restricted stock units, Shares     5,445          
Stock-based compensation expense 3,313       3,313      
Unrealized loss on marketable securities (58)           (58)  
Net loss (17,812)             (17,812)
Ending Balance at Jun. 30, 2026 $ 119,533   $ 7   $ 516,336   $ (117) $ (396,693)
Ending Balance, shares at Jun. 30, 2026     69,259,517